DPYD and adenocarcinoma: An in vitro study revealed that EGFR mutant cells were less sensitive to fluorouracil than were EGFR wild-type cells [18] High expression of DPD, a 5-fluorouracil degrading enzyme, correlated with EGFR mutation in adenocarcinoma cells and tissues.